FI102612B - Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi

Info

Publication number: FI102612B
Authority: FI; Finland
Prior art keywords: heptacoses; tricyclo; stripping; derivatives; therapeutically useful
Prior art date: 1992-05-07

Application number

FI932035A

Other languages

English (en)

Swedish (sv)

Other versions

FI932035A (fi

FI102612B1 (fi

FI932035A0 (fi

Inventor

Karl Baumann

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-07

Filing date

1993-05-05

Publication date

1999-01-15

1992-05-07 Priority claimed from GB929209815A external-priority patent/GB9209815D0/en

1993-03-10 Priority claimed from GB939304927A external-priority patent/GB9304927D0/en

1993-05-05 Application filed by Novartis Ag filed Critical Novartis Ag

1993-05-05 Publication of FI932035A0 publication Critical patent/FI932035A0/fi

1993-11-08 Publication of FI932035A publication Critical patent/FI932035A/fi

1998-11-16 Priority to FI982476A priority Critical patent/FI982476A0/fi

1999-01-15 Application granted granted Critical

1999-01-15 Publication of FI102612B publication Critical patent/FI102612B/fi

1999-01-15 Publication of FI102612B1 publication Critical patent/FI102612B1/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Transplantation (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Saccharide Compounds (AREA)

FI932035A 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo[18.6.1.0 ]heptakoseenien ja niiden johdannaisten valmistamiseksi FI102612B1 (fi)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
FI982476A FI982476A0 (fi)	1992-05-07	1998-11-16	Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929209815A GB9209815D0 (en)	1992-05-07	1992-05-07	Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en)	1993-03-10	1993-03-10	Organic compounds

Publications (4)

Publication Number	Publication Date
FI932035A0 FI932035A0 (fi)	1993-05-05
FI932035A FI932035A (fi)	1993-11-08
FI102612B true FI102612B (fi)	1999-01-15
FI102612B1 FI102612B1 (fi)	1999-01-15

Family

ID=26300836

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FI932035A FI102612B1 (fi)	1992-05-07	1993-05-05	Menetelmä terapeuttisesti käyttökelpoisten trisyklo[18.6.1.0 ]heptakoseenien ja niiden johdannaisten valmistamiseksi
FI982476A FI982476A0 (fi)	1992-05-07	1998-11-16	Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
FI982476A FI982476A0 (fi)	1992-05-07	1998-11-16	Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Country Status (25)

Country	Link
US (1)	US5514685A (fi)
EP (1)	EP0569337B1 (fi)
JP (1)	JP2788392B2 (fi)
KR (1)	KR100292311B1 (fi)
CN (1)	CN1037773C (fi)
AT (1)	ATE155787T1 (fi)
AU (1)	AU668152B2 (fi)
CA (1)	CA2095659C (fi)
CY (1)	CY2126B1 (fi)
CZ (1)	CZ291773B6 (fi)
DE (1)	DE69312386T2 (fi)
DK (1)	DK0569337T3 (fi)
ES (1)	ES2105193T3 (fi)
FI (2)	FI102612B1 (fi)
GR (1)	GR3024754T3 (fi)
HU (2)	HUT66531A (fi)
IL (1)	IL105607A (fi)
MY (1)	MY109602A (fi)
NO (1)	NO305865B1 (fi)
NZ (1)	NZ247553A (fi)
PH (1)	PH30456A (fi)
RU (1)	RU2126009C1 (fi)
SG (1)	SG47011A1 (fi)
SK (1)	SK282061B6 (fi)
TW (1)	TW330936B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY110603A (en) *	1993-05-27	1998-08-29	Novartis Ag	Tetrahydropyran derivatives
KR100434682B1 (ko)	1994-10-26	2004-08-18	노바티스 아게	약학조성물
MY129435A (en)	1994-10-26	2007-04-30	Novartis Ag	Pharmaceutical microemulsion preconcentrates
AU749623B2 (en)	1998-03-26	2002-06-27	Astellas Pharma Inc.	Sustained release preparations
GB9826656D0 (en)	1998-12-03	1999-01-27	Novartis Ag	Organic compounds
US7063857B1 (en)	1999-04-30	2006-06-20	Sucampo Ag	Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en)	2000-04-10	2000-05-31	Novartis Ag	Organic compounds
WO2004009056A1 (en)	2002-07-23	2004-01-29	Novartis Ag	Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
KR100469917B1 (ko) *	2002-09-09	2005-02-02	(주)조은식품	구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) *	2005-12-16	2007-08-03	주식회사농심	조직감이 향상된 사출 스낵 및 그 제조 방법
CN102958935B (zh) *	2010-04-02	2015-12-09	爱尔兰詹森科学公司	大环整合酶抑制剂
JPWO2016068208A1 (ja)	2014-10-28	2017-08-10	晃史山口	妊娠状態を改善するための薬剤及びその利用
JP7465806B2 (ja)	2018-08-10	2024-04-11	晃史山口	母体と胎児との関係における液性免疫関連疾患の治療薬
CA3123535A1 (en)	2018-12-18	2020-06-25	Koushi Yamaguchi	Agent for improving infertility, recurrent miscarriage, and state of pregnancy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4894366A (en) *	1984-12-03	1990-01-16	Fujisawa Pharmaceutical Company, Ltd.	Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) *	1984-12-03	1993-10-19	Fujisawa Pharmaceutical Company, Ltd.	Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CA1316916C (en) *	1988-10-12	1993-04-27	David Askin	Hydroxide mediated fk-506 rearrangement product
EP0364031B1 (en) *	1988-10-12	1992-12-23	Merck & Co. Inc.	Hydroxide mediated fk-506 rearrangement process
JPH04500372A (ja) *	1989-06-14	1992-01-23	サンド・リミテッド	異種原子含有三環式化合物
EP0413532A3 (en) *	1989-08-18	1991-05-15	Fisons Plc	Macrocyclic compounds
IE904050A1 (en) *	1989-11-13	1991-05-22	Merck & Co Inc	Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) *	1990-03-01	1993-11-09	Fujisawa Pharmaceutical Co., Ltd.	Pharmaceutical solution containing FK-506
GB2246350A (en) *	1990-07-23	1992-01-29	Fujisawa Pharmaceutical Co	Tricyclo compounds
EP0480623A1 (en) *	1990-10-11	1992-04-15	Merck & Co. Inc.	New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) *	1991-02-05	1992-08-20	Fujisawa Pharmaceutical Co., Ltd.	Lactone compounds
DE69232630T2 (de) *	1991-09-05	2003-10-09	Abbott Laboratories, Abbott Park	Makrocyclische immunmodulatoren

1993
- 1993-04-22 HU HU9301190A patent/HUT66531A/hu unknown
- 1993-05-04 EP EP93810325A patent/EP0569337B1/en not_active Expired - Lifetime
- 1993-05-04 SG SG1996001883A patent/SG47011A1/en unknown
- 1993-05-04 DE DE69312386T patent/DE69312386T2/de not_active Expired - Lifetime
- 1993-05-04 ES ES93810325T patent/ES2105193T3/es not_active Expired - Lifetime
- 1993-05-04 DK DK93810325.6T patent/DK0569337T3/da active
- 1993-05-04 AT AT93810325T patent/ATE155787T1/de not_active IP Right Cessation
- 1993-05-05 NO NO931627A patent/NO305865B1/no not_active IP Right Cessation
- 1993-05-05 NZ NZ247553A patent/NZ247553A/en not_active IP Right Cessation
- 1993-05-05 CZ CZ1993829A patent/CZ291773B6/cs not_active IP Right Cessation
- 1993-05-05 MY MYPI93000847A patent/MY109602A/en unknown
- 1993-05-05 IL IL105607A patent/IL105607A/en not_active IP Right Cessation
- 1993-05-05 SK SK435-93A patent/SK282061B6/sk not_active IP Right Cessation
- 1993-05-05 PH PH46144A patent/PH30456A/en unknown
- 1993-05-05 FI FI932035A patent/FI102612B1/fi not_active IP Right Cessation
- 1993-05-06 AU AU38393/93A patent/AU668152B2/en not_active Ceased
- 1993-05-06 CN CN93106551A patent/CN1037773C/zh not_active Expired - Fee Related
- 1993-05-06 CA CA002095659A patent/CA2095659C/en not_active Expired - Fee Related
- 1993-05-06 JP JP5105392A patent/JP2788392B2/ja not_active Expired - Fee Related
- 1993-05-06 KR KR1019930007766A patent/KR100292311B1/ko not_active IP Right Cessation
- 1993-05-06 RU RU93005029A patent/RU2126009C1/ru not_active IP Right Cessation
- 1993-05-08 TW TW082103599A patent/TW330936B/zh not_active IP Right Cessation
1995
- 1995-05-15 US US08/441,492 patent/US5514685A/en not_active Expired - Lifetime
- 1995-06-19 HU HU95P/P00246P patent/HU211135A9/hu unknown
1997
- 1997-09-17 GR GR970402399T patent/GR3024754T3/el unknown
1998
- 1998-11-16 FI FI982476A patent/FI982476A0/fi unknown
1999
- 1999-02-03 CY CY9900004A patent/CY2126B1/xx unknown

Also Published As

Publication number	Publication date
CA2095659A1 (en)	1993-11-08
KR100292311B1 (ko)	2001-09-17
FI932035A (fi)	1993-11-08
CA2095659C (en)	2005-08-09
JP2788392B2 (ja)	1998-08-20
MY109602A (en)	1997-03-31
DE69312386D1 (de)	1997-08-28
SK43593A3 (en)	1995-07-11
JPH0641144A (ja)	1994-02-15
AU668152B2 (en)	1996-04-26
US5514685A (en)	1996-05-07
AU3839393A (en)	1993-11-11
HU9301190D0 (en)	1993-07-28
SK282061B6 (sk)	2001-10-08
NO931627D0 (no)	1993-05-05
CZ291773B6 (cs)	2003-05-14
TW330936B (en)	1998-05-01
FI102612B1 (fi)	1999-01-15
IL105607A (en)	1998-01-04
CY2126B1 (en)	2002-06-21
DE69312386T2 (de)	1998-01-29
RU2126009C1 (ru)	1999-02-10
SG47011A1 (en)	1998-03-20
EP0569337A1 (en)	1993-11-10
HUT66531A (en)	1994-12-28
ATE155787T1 (de)	1997-08-15
IL105607A0 (en)	1993-09-22
NZ247553A (en)	1995-07-26
NO931627L (no)	1993-11-08
GR3024754T3 (en)	1997-12-31
CN1083486A (zh)	1994-03-09
PH30456A (en)	1997-05-28
EP0569337B1 (en)	1997-07-23
KR940005631A (ko)	1994-03-22
CZ82993A3 (en)	1994-01-19
DK0569337T3 (da)	1998-01-19
CN1037773C (zh)	1998-03-18
ES2105193T3 (es)	1997-10-16
NO305865B1 (no)	1999-08-09
FI982476A0 (fi)	1998-11-16
HU211135A9 (en)	1995-10-30
FI932035A0 (fi)	1993-05-05

Publication	Publication Date	Title
SG47520A1 (en)	1998-04-17	New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
ITMI930699A0 (it)	1993-04-08	Nuovi derivati dell'indolo
FI102612B (fi)	1999-01-15	Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 \|heptako seenien ja niiden johdannaisten valmistamiseksi
DE69319976D1 (de)	1998-09-03	7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
EG20279A (en)	1998-05-31	New derivatives of 3 arylpyrazoles used as fungicides
PL300068A1 (en)	1994-02-21	9-(substituted glycil) amido-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts or metal complexes, pharmaceutical agent and veterinari agent
FI954718A0 (fi)	1995-10-04	Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
FI103666B1 (fi)	1999-08-13	Menetelmä bifenyylijohdannaisen valmistamiseksi
FI940769A0 (fi)	1994-02-18	Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI906407A0 (fi)	1990-12-27	Menetelmä kestävän teräksen valmistamiseksi
AU2578292A (en)	1993-04-05	5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
EP0458160A3 (en)	1992-03-18	Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents
ITMI931685A1 (it)	1995-01-28	Derivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici
ITMI931019A0 (it)	1993-05-18	Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
FI953106A (fi)	1995-07-13	Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
FI101817B1 (fi)	1998-08-31	Menetelmä suprajohtavien seosten valmistamiseksi
BR9407889A (pt)	1996-10-29	Derivados 2(pyrazol-3-yl)carbapenem
NO178540C (no)	1996-04-17	Bisfenyletanderivater, farmasöytisk preparat derav samt anvendelse
FI990752A0 (fi)	1999-04-06	Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä
ITMI921593A0 (it)	1992-06-30	Articoli formati per uso biomedicale
FI950101A0 (fi)	1995-01-09	4-oksa-1-atsabisyklo 3,2,0 -7heptanoni-johdannaiset kasvainten vastaisina aineina
FI912247A0 (fi)	1991-05-09	Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi
ATE158293T1 (de)	1997-10-15	Polycyclische 31668p- und 31668u-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antibiotische oder antitumorale arzneistoffe
AU636033C (en)	1993-12-23	Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents
ZA913866B (en)	1992-02-26	Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents

Legal Events

Date	Code	Title	Description
1993-05-05	FG	Patent granted	Owner name: NOVARTIS AG
1997-08-20	GB	Transfer or assigment of application	Owner name: NOVARTIS AG
2011-12-30	MM	Patent lapsed